| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 1/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for E1LV34 from our risk checks.
Elevance Health, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$478.24 |
| 52 Week High | US$638.82 |
| 52 Week Low | US$449.05 |
| Beta | 0.85 |
| 11 Month Change | -12.92% |
| 3 Month Change | -19.07% |
| 1 Year Change | n/a |
| 33 Year Change | 0.39% |
| 5 Year Change | n/a |
| Change since IPO | 99.52% |
Recent News & Updates
Recent updates
Shareholder Returns
| E1LV34 | BR Healthcare | BR Market | |
|---|---|---|---|
| 7D | -0.07% | -4.1% | -1.5% |
| 1Y | n/a | -11.4% | 1.8% |
Return vs Industry: Insufficient data to determine how E1LV34 performed against the BR Healthcare industry.
Return vs Market: Insufficient data to determine how E1LV34 performed against the BR Market.
Price Volatility
| E1LV34 volatility | |
|---|---|
| E1LV34 Average Weekly Movement | 5.9% |
| Healthcare Industry Average Movement | 6.3% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in BR Market | 8.9% |
| 10% least volatile stocks in BR Market | 2.3% |
Stable Share Price: E1LV34 has not had significant price volatility in the past 3 months compared to the BR market.
Volatility Over Time: Insufficient data to determine E1LV34's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 104,900 | Gail Boudreaux | www.elevancehealth.com |
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Elevance Health, Inc. Fundamentals Summary
| E1LV34 fundamental statistics | |
|---|---|
| Market cap | R$567.93b |
| Earnings (TTM) | R$36.95b |
| Revenue (TTM) | R$1.00t |
14.9x
P/E Ratio0.6x
P/S RatioIs E1LV34 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| E1LV34 income statement (TTM) | |
|---|---|
| Revenue | US$174.02b |
| Cost of Revenue | US$125.40b |
| Gross Profit | US$48.61b |
| Other Expenses | US$42.20b |
| Earnings | US$6.42b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 27.67 |
| Gross Margin | 27.94% |
| Net Profit Margin | 3.69% |
| Debt/Equity Ratio | 61.9% |
How did E1LV34 perform over the long term?
See historical performance and comparisonDividends
1.6%
Current Dividend Yield23%
Payout RatioDoes E1LV34 pay a reliable dividends?
See E1LV34 dividend history and benchmarks| Elevance Health dividend dates | |
|---|---|
| Ex Dividend Date | Dec 04 2024 |
| Dividend Pay Date | Dec 30 2024 |
| Days until Ex dividend | 21 days |
| Days until Dividend pay date | 47 days |
Does E1LV34 pay a reliable dividends?
See E1LV34 dividend history and benchmarks